Literature DB >> 23091100

Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines.

Wendy Landier1, Saro H Armenian, Jin Lee, Ola Thomas, F Lennie Wong, Liton Francisco, Claudia Herrera, Clare Kasper, Karla D Wilson, Meghan Zomorodi, Smita Bhatia.   

Abstract

PURPOSE: The Children's Oncology Group Long-Term Follow-Up (COG-LTFU) Guidelines use consensus-based recommendations for exposure-driven, risk-based screening for early detection of long-term complications in childhood cancer survivors. However, the yield from these recommendations is not known.
METHODS: Survivors underwent COG-LTFU Guideline-directed screening. Yield was classified as negligible/negative (< 1%), intermediate (≥ 1% to < 10%), or high (≥ 10%). For long-term complications with high yield, logistic regression was used to identify subgroups more likely to screen positive.
RESULTS: Over the course of 1,188 clinic visits, 370 childhood cancer survivors (53% male; 47% Hispanic; 69% leukemia/lymphoma survivors; median age at diagnosis, 11.1 years [range, 0.3 to 21.9 years]; time from diagnosis, 10.5 years [range, 5 to 55.8 years]) underwent 4,992 screening tests. High-yield tests included thyroid function (hypothyroidism, 10.1%), audiometry (hearing loss, 22.6%), dual-energy x-ray absorptiometry scans (low bone mineral density [BMD], 23.2%), serum ferritin (iron overload, 24.0%), and pulmonary function testing/chest x-ray (pulmonary dysfunction, 84.1%). Regression analysis failed to identify subgroups more likely to result in high screening yield, with the exception of low BMD (2.5-fold increased risk for males [P = .04]; 3.3-fold increased risk for nonobese survivors [P = .01]). Screening tests with negligible/negative (< 1%) yield included complete blood counts (therapy-related leukemia), dipstick urinalysis for proteinuria and serum blood urea nitrogen/creatinine (glomerular defects), microscopic urinalysis for hematuria (hemorrhagic cystitis, bladder cancer), ECG (anthracycline-related conduction disorder), and hepatitis B and HIV serology.
CONCLUSION: Screening tests with a high yield are appropriate for risk groups targeted for screening by the COG-LTFU Guidelines. Elimination of screening tests with negligible/negative yield should be given consideration.

Entities:  

Mesh:

Year:  2012        PMID: 23091100      PMCID: PMC3515770          DOI: 10.1200/JCO.2012.43.4951

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  77 in total

1.  Medical assessment of adverse health outcomes in long-term survivors of childhood cancer.

Authors:  Maud M Geenen; Mathilde C Cardous-Ubbink; Leontien C M Kremer; Cor van den Bos; Helena J H van der Pal; Richard C Heinen; Monique W M Jaspers; Caro C E Koning; Foppe Oldenburger; Nelia E Langeveld; Augustinus A M Hart; Piet J M Bakker; Huib N Caron; Flora E van Leeuwen
Journal:  JAMA       Date:  2007-06-27       Impact factor: 56.272

Review 2.  Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings.

Authors:  Lisa Diller; Eric J Chow; James G Gurney; Melissa M Hudson; Nina S Kadin-Lottick; Toana I Kawashima; Wendy M Leisenring; Lillian R Meacham; Ann C Mertens; Daniel A Mulrooney; Kevin C Oeffinger; Roger J Packer; Leslie L Robison; Charles A Sklar
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

3.  Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development.

Authors:  S C Kaste; D Jones-Wallace; S R Rose; J M Boyett; R H Lustig; G K Rivera; C H Pui; M M Hudson
Journal:  Leukemia       Date:  2001-05       Impact factor: 11.528

4.  Partial reversibility of cisplatin nephrotoxicity in children.

Authors:  P R Brock; D E Koliouskas; T M Barratt; E Yeomans; J Pritchard
Journal:  J Pediatr       Date:  1991-04       Impact factor: 4.406

5.  The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors.

Authors:  A Gerl; D Mühlbayer; G Hansmann; W Mraz; W Hiddemann
Journal:  Cancer       Date:  2001-04-01       Impact factor: 6.860

6.  Volumetric bone mineral density in patients with childhood craniopharyngioma.

Authors:  H L Müller; P Schneider; K Bueb; N Etavard-Gorris; U Gebhardt; R Kolb; N Sörensen
Journal:  Exp Clin Endocrinol Diabetes       Date:  2003-05       Impact factor: 2.949

7.  Iron overload following bone marrow transplantation in children: MR findings.

Authors:  L Kornreich; G Horev; I Yaniv; J Stein; M Grunebaum; R Zaizov
Journal:  Pediatr Radiol       Date:  1997-11

Review 8.  Bone-mineral density deficits from childhood cancer and its therapy. A review of at-risk patient cohorts and available imaging methods.

Authors:  Sue C Kaste
Journal:  Pediatr Radiol       Date:  2004-02-12

Review 9.  Pulmonary toxicity of antineoplastic therapy.

Authors:  H Kreisman; N Wolkove
Journal:  Semin Oncol       Date:  1992-10       Impact factor: 4.929

10.  Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States.

Authors:  E M Lackritz; G A Satten; J Aberle-Grasse; R Y Dodd; V P Raimondi; R S Janssen; W F Lewis; E P Notari; L R Petersen
Journal:  N Engl J Med       Date:  1995-12-28       Impact factor: 91.245

View more
  37 in total

Review 1.  Collaborative Research in Childhood Cancer Survivorship: The Current Landscape.

Authors:  Smita Bhatia; Saro H Armenian; Gregory T Armstrong; Eline van Dulmen-den Broeder; Michael M Hawkins; Leontien C M Kremer; Claudia E Kuehni; Jørgen H Olsen; Leslie L Robison; Melissa M Hudson
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

2.  Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE).

Authors:  Daniel M Green; Liang Zhu; Mingjuan Wang; Kirsten K Ness; Matthew J Krasin; Nickhill H Bhakta; M Beth McCarville; Saumini Srinivasan; Dennis C Stokes; DeoKumar Srivastava; Rohit Ojha; Kyla Shelton; Ching-Hon Pui; Gregory T Armstrong; Daniel A Mulrooney; Monika Metzger; Sheri L Spunt; Fariba Navid; Andrew M Davidoff; Bhaskar N Rao; Leslie L Robison; Melissa M Hudson
Journal:  Ann Am Thorac Soc       Date:  2016-09

3.  Long-term pulmonary function in survivors of childhood cancer.

Authors:  Saro H Armenian; Wendy Landier; Liton Francisco; Claudia Herrera; George Mills; Aida Siyahian; Natt Supab; Karla Wilson; Julie A Wolfson; David Horak; Smita Bhatia
Journal:  J Clin Oncol       Date:  2015-04-06       Impact factor: 44.544

Review 4.  Frailty in childhood cancer survivors.

Authors:  Kirsten K Ness; Gregory T Armstrong; Mondira Kundu; Carmen L Wilson; Tamara Tchkonia; James L Kirkland
Journal:  Cancer       Date:  2014-12-19       Impact factor: 6.860

Review 5.  Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors:  Saro H Armenian; Melissa M Hudson; Renee L Mulder; Ming Hui Chen; Louis S Constine; Mary Dwyer; Paul C Nathan; Wim J E Tissing; Sadhna Shankar; Elske Sieswerda; Rod Skinner; Julia Steinberger; Elvira C van Dalen; Helena van der Pal; W Hamish Wallace; Gill Levitt; Leontien C M Kremer
Journal:  Lancet Oncol       Date:  2015-03       Impact factor: 41.316

Review 6.  Surveillance for Late Effects in Childhood Cancer Survivors.

Authors:  Wendy Landier; Roderick Skinner; W Hamish Wallace; Lars Hjorth; Renée L Mulder; F Lennie Wong; Yutaka Yasui; Nickhill Bhakta; Louis S Constine; Smita Bhatia; Leontien C Kremer; Melissa M Hudson
Journal:  J Clin Oncol       Date:  2018-06-06       Impact factor: 44.544

7.  Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment.

Authors:  Eric J Chow; Kasey J Leger; Neel S Bhatt; Daniel A Mulrooney; Colin J Ross; Sanjeev Aggarwal; Neha Bansal; Matthew J Ehrhardt; Saro H Armenian; Jessica M Scott; Borah Hong
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

8.  Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study.

Authors:  Gregory T Armstrong; Toana Kawashima; Wendy Leisenring; Kayla Stratton; Marilyn Stovall; Melissa M Hudson; Charles A Sklar; Leslie L Robison; Kevin C Oeffinger
Journal:  J Clin Oncol       Date:  2014-03-17       Impact factor: 44.544

9.  Milestones in the curability of pediatric cancers.

Authors:  Melissa M Hudson; Michael P Link; Joseph V Simone
Journal:  J Clin Oncol       Date:  2014-04-14       Impact factor: 44.544

Review 10.  Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.

Authors:  Lois B Travis; Wendy Demark Wahnefried; James M Allan; Marie E Wood; Andrea K Ng
Journal:  Nat Rev Clin Oncol       Date:  2013-03-26       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.